Prosthetic Heart Valve Market: Hospitals End User Segment Likely to Project Increased Revenue Growth Through 2026: Global Industry Analysis & Opportunity Assessment, 2016-2026
- REP-GB-666
- 2016-10-20
- 134 Pages
- Format:
- Category: Healthcare, Pharmaceuticals and Medical devices
Mechanical heart valve is an artificial heart valve implanted in patients suffering from indicated diseases such as aortic stenosis or mitral regurgitation. Tissue heart valves are the biological valves harvested from cow heart sac (bovine) or porcine (pig) heart valves mounted on a stent or used without a stent to replace a dysfunctional heart valve. The global prosthetic heart valve market revenue is projected to register a CAGR of 12.0% during the forecast period (2016-2026) and reach a market valuation of US$ 19.60 Bn by the end of 2026.
Rising prevalence of valvular heart disease (VHD) expected to augment market growth
Increasing occurrences of valvular heart disease (VHD) is one of the primary drivers impacting the global prosthetic heart valve market. Other factors fuelling the demand for prosthetic heart valves include regulatory approval for heart valves, integration of technological advancements, and increasing number of heart valve implantation procedures. Prosthetic heart values are an effective alternative to cumbersome open heart surgery, and this is one of the main reasons for a global preference for prosthetic heart valves.
However, high costs associated with transcatheter heart valve products, procedure related risks and complications, and product recalls are some restraints likely to hamper the growth of the global prosthetic heart valve market over the forecast period.
Market segmentation
|
By Product Type |
By End User |
By Region |
|---|---|---|
|
|
|
Tissue Heart Valves product type segment expected to dominate the global prosthetic heart valve market in terms of value
The Tissue Heart Valves segment is anticipated to register a CAGR of 12.2% during the forecast period. The Transcatheter Heart Valves segment accounted for 27.2% value share of the global prosthetic heart valve market in 2015 and is estimated to account for over 31.0% revenue share of the global prosthetic heart valve market by the end of 2026.
Hospitals end user segment likely to project increased revenue growth during the forecast period
The Hospitals segment is anticipated to be valued at US$ 4,717.2 Mn by the end of 2016 and register a CAGR of 12.2% over the forecast period to reach a market valuation of US$ 14.9 Bn by the end of 2026. The Hospitals segment is projected to remain dominant in the global prosthetic heart valve market in terms of value over the forecast period, attributed to a large number of cardiac patients opting for hospitals to undergo treatment.
North America, Western Europe, and APEJ expected to be the fastest growing regional markets throughout the forecast period
North America and Western Europe accounted for over half the revenue share of the global prosthetic heart valve market in 2015. The North America prosthetic heart valve market accounted for a market share of 41.0% in 2015 and is expected to retain its dominance in terms of revenue in the global prosthetic heart valve market throughout the forecast period. Increased THV procedures coupled with rising adoption of technological advancements in an effort to reduce treatment duration for high conventional surgical risk patients is expected to result in significant growth of the global prosthetic heart valve market in North America. The Western Europe prosthetic heart valve market is expected to account for the second largest market value share owing to product maturity and increased awareness levels among the population in the region.
Leading market players are concentrating on providing differentiated treatment options to patients to retain market share
Edwards Lifesciences Corporation, St. Jude Medical, Inc., Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, SYMETIS, LivaNova PLC, CryoLife, Inc., Braile Biomedica, Colibri Heart Valve LLC, and JenaValve Technology, Inc. are some of the leading players operating in the global prosthetic heart valve market. Top companies are focussing on delivering differentiated therapies to cardiac patients and are strengthening their foothold in the global prosthetic heart valve market through strategic collaborations and acquisitions.
In a new publication titled “Prosthetic Heart Valve Market: Global Industry Analysis & Opportunity Assessment, 2016–2026” Future Market Insights examines the global prosthetic heart valve market performance over a 10-year forecast period 2016–2026. Our primary objective is to offer updates and information related to market opportunities in the global prosthetic heart valve market. Our comprehensive study demonstrates market dynamics that are expected to influence the current environment and future status of the global prosthetic heart valve market. In this report, we have focussed on market performance and identified the drivers, restraints, and trends likely to influence the global prosthetic heart valve market over the forecast period. We have also provided information on opportunities available for manufacturers and key players operating in the global prosthetic heart valve market.
Report description
The global prosthetic heart valve market report begins by defining prosthetic heart valves, types of prosthetic heart valves, and the relevance and impact of forecast factors used to estimate the global prosthetic heart valve market value. This is followed by an overview of key market dynamics likely to influence the global prosthetic heart valve market, including our comprehensive analysis of key trends, drivers, restraints, and market opportunities. We have also included an impact analysis of key growth drivers and restraints based on the weighted average model to better equip readers with meaningful insights on ongoing developments in the global prosthetic heart valve market.
Based on product type, the global prosthetic heart valve market has been segmented into Mechanical Heart Valves (Mechanical Aortic Valve & Mechanical Mitral Valve), Biological/Tissue Heart Valves (Tissue Aortic Valve & Tissue Mitral Valve), and Transcatheter Heart Valves (Transcatheter Aortic Valve & Transcatheter Mitral Valve). Based on end user, the market has been segmented into Hospitals & Ambulatory Surgery Centres. A detailed analysis has been provided for these segment in terms of market size, Y-o-Y growth rate, and BPS analysis. The next section of the report highlights the global prosthetic heart valve market by region and provides a market outlook for 2016–2026. The report also discusses key regional trends contributing to the revenue growth of the global prosthetic heart valve market and analyses the impact of drivers and restraints in each region. Key regions assessed in this report include North America, Latin America Excluding Brazil, Brazil, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan, and Middle East & Africa (MEA). The above sections—by product type, end user and region—evaluate the present scenario and growth prospects of the global prosthetic heart valve market for the period 2016–2026. We have considered 2015 as the base year and provided data for the forecast period, i.e., 2016–2026.
In the final section of the report on the global prosthetic heart valve market, we have included a competitive landscape to provide report audiences with a dashboard view based on categories of manufacturers operating in the global prosthetic heart valve market. This section is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment in the global prosthetic heart valve market value chain. Report audiences can gain segment-specific company insights to identify and evaluate key competitors based on in-depth assessment of capabilities and successes in the global prosthetic heart valve market. We have profiled some of the leading companies dominating the global prosthetic heart valve market and evaluated their long- and short-term strategies, key offerings, SWOT analysis, and recent developments in the global prosthetic heart valve market. Key competitors covered in the global prosthetic heart valve market report are Edwards Lifesciences Corporation, St. Jude Medical, Inc., Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, SYMETIS, LivaNova PLC, CryoLife, Inc., Braile Biomedica, Colibri Heart Valve LLC, and JenaValve Technology, Inc.
Research methodology
To ascertain the global prosthetic heart valve market size, we have considered revenue generated by companies functioning in the global prosthetic heart valve market. The forecast presented in our report assesses the total revenue by value across the global prosthetic heart valve market. In order to offer an accurate forecast, we have started by sizing the current market, which forms the basis of how the global prosthetic heart valve market is expected to develop in the future. Given the characteristics of the market, we have triangulated the outcome of three different types of analysis based on supply side, downstream industry demand, and the overall economic envelope.
Given the ever-fluctuating nature of the global economy, we have conducted our forecasts not only in terms of CAGR, but have also analysed the global prosthetic heart valve market on the basis of key parameters such as Year-on-Year (Y-o-Y) growth to understand market predictability and to identify the right opportunities across the global prosthetic heart valve market. The different segments of the global prosthetic heart valve market are analysed in terms of Basis Point Share (BPS) to understand individual segments’ relative contribution to market growth. This detailed level of information is important for identifying various key trends governing the global prosthetic heart valve market.
Further, to understand key growth segments in terms of growth and adoption of prosthetic heart valves globally, we have developed the global prosthetic heart valve market attractiveness index to help providers identify real market opportunities in the global prosthetic heart valve market.